This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why You Should Retain Ecolab (ECL) Stock Right Now
by Zacks Equity Research
Ecolab (ECL) continues to gain traction from a solid product portfolio and segmental strength. However, segmental weakness remains a woe.
Why Is Ecolab (ECL) Up 4.6% Since Last Earnings Report?
by Zacks Equity Research
Ecolab (ECL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ecolab (ECL) Q3 Earnings & Revenues Beat Mark, Margins Down
by Zacks Equity Research
Ecolab's (ECL) robust performance across the majority of its segments drives its Q3 sales despite pandemic-led business challenges.
Ecolab (ECL) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Ecolab (ECL) delivered earnings and revenue surprises of 6.98% and 1.13%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Ecolab (ECL) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Ecolab's (ECL) third-quarter results are likely to reflect continued strength across its business segments.
Ecolab (ECL) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Ecolab (ECL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is Ecolab (ECL) Up 2.3% Since Last Earnings Report?
by Zacks Equity Research
Ecolab (ECL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ecolab (ECL) Inks New Innovative Deal With Manchester United
by Zacks Equity Research
Ecolab (ECL) collaborates with Manchester United (MANU) to advance hygiene and sustainable practices across Old Trafford and the Carrington training ground.
4 Stocks to Watch From the Rebounding Chemical Specialty Industry
by Anindya Barman
The Zacks Chemicals Specialty industry is poised benefit from a rebound in global industrial and manufacturing activities. ESI, MTX, ASIX and HWKN are set to gain from demand recovery and strategic actions.
Ecolab (ECL) Q2 Earnings & Revenues Beat Mark, Margins Rise
by Zacks Equity Research
Ecolab's (ECL) robust performances across majority of its segments drive its Q2 sales despite pandemic-led business challenges.
Ecolab (ECL) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Ecolab (ECL) delivered earnings and revenue surprises of 3.39% and 2.29%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Ecolab (ECL) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Ecolab's (ECL) second-quarter results are likely to reflect continued strength in the Global Healthcare and Life Sciences segment.
Materials ETFs Set to Gain As Q2 Earnings Unfold
by Sweta Killa
With earnings surprises in the cards for many companies, materials ETFs might see smooth trading in the weeks ahead.
Ecolab (ECL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Ecolab (ECL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Top Stock Reports for Exxon Mobil, Eli Lilly & Costco
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil (XOM), Eli Lilly (LLY), and Costco Wholesale (COST).
Here's Why You Should Retain Ecolab (ECL) Stock Right Now
by Zacks Equity Research
Ecolab (ECL) continues to gain traction for a solid product portfolio and cost-efficiency program. However, segmental weakness remains a woe.
The Zacks Analyst Blog Highlights: Salesforce, Shopify, AstraZeneca, Micron and Ecolab
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Salesforce, Shopify, AstraZeneca, Micron and Ecolab
Top Research Reports for salesforce, Shopify & AstraZeneca
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including salesforce.com (CRM), Shopify (SHOP), and AstraZeneca (AZN).
Ecolab (ECL) to Aid Life Sciences Industry With New Offering
by Zacks Equity Research
Ecolab (ECL) unveils new virtual service offering to help the life sciences industry to address cleaning and disinfection challenges.
Why Is Ecolab (ECL) Down 3.2% Since Last Earnings Report?
by Zacks Equity Research
Ecolab (ECL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Retain Ecolab (ECL) Stock Right Now
by Zacks Equity Research
Ecolab (ECL) continues to gain traction for a solid product portfolio and cost-efficiency program. However, segmental weakness remains a woe.
Ecolab (ECL) Launches Roach Control Device for Food Outlets
by Zacks Equity Research
Ecolab's (ECL) latest device is expected to help the restaurant industry efficiently protect their brand reputation and eliminate any business and public health risk.
MTX or ECL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MTX vs. ECL: Which Stock Is the Better Value Option?
AXTA vs. ECL: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
AXTA vs. ECL: Which Stock Is the Better Value Option?
Ecolab (ECL) Misses Q1 Earnings Estimates
by Zacks Equity Research
Ecolab (ECL) delivered earnings and revenue surprises of -1.22% and 0.86%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?